Type something and hit enter

ads here
On
advertise here

Debt rose by ~ $6bn, yet Biogen's cash on hand did not increase. Moreover, it did not make any large acquisitions recently. Does any have any idea why this may have happened?



Submitted July 11, 2017 at 09:35AM by mrtylerrr http://ift.tt/2tachVf

Click to comment